MoodSpark buys Dthera Sciences

Market Intelligence

May 11, 2022

Telememory Holding Corp., the makers of the startup MoodSpark acquired Dthera Sciences, which provides cognitive behavioral therapy for older adults with cognitive decline. Financial terms were not disclosed. The deal brings a large intellectual property portfolio under the MoodSpark banner including an FDA Breakthrough device designation, several patents, a technology platform, and clinical pilot research. Dthera Sciences developed a system for treating acute episodes of anxiety, agitation and depression in elderly patients suffering from neurodegenerative diseases including Alzheimer's and dementia.